0001465818-20-000008.txt : 20200310 0001465818-20-000008.hdr.sgml : 20200310 20200310092246 ACCESSION NUMBER: 0001465818-20-000008 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200310 DATE AS OF CHANGE: 20200310 EFFECTIVENESS DATE: 20200310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hancock Jaffe Laboratories, Inc. CENTRAL INDEX KEY: 0001661053 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330936180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-362348 FILM NUMBER: 20700105 BUSINESS ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-261-2900 MAIL ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 D 1 primary_doc.xml X0708 D LIVE 0001661053 Hancock Jaffe Laboratories, Inc. 70 DOPPLER IRVINE CA CALIFORNIA 92618 949-261-2900 DELAWARE None None Corporation true Robert A. Berman 70 Doppler Irvine CA CALIFORNIA 92618 Executive Officer Director Francis Duhay, M.D. 70 Doppler Irvine CA CALIFORNIA 92618 Director Sanjay Shrivastava 70 Doppler Irvine CA CALIFORNIA 92618 Director Marc H. Glickman, M.D. 70 Doppler Irvine CA CALIFORNIA 92618 Executive Officer Robert Rankin 70 Doppler Irvine CA CALIFORNIA 92618 Executive Officer Matthew M. Jenusaitis 70 Doppler Irvine CA CALIFORNIA 92618 Director Robert C. Gray 70 Doppler Irvine CA CALIFORNIA 92618 Director Biotechnology Decline to Disclose 06b false 2020-02-25 false true true true false 0 Spartan Capital Securities LLC 146251 None None 45 Broadway New York NY NEW YORK 10006 All States false 890000 650000 240000 false 9 65000 true 0 0 false Hancock Jaffe Laboratories, Inc. /s/ Robert Rankin Robert Rankin Chief Financial Officer 2020-03-10